Found: 187
Select item for more details and to access through your institution.
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1390, doi. 10.1007/s10637-019-00888-z
- By:
- Publication type:
- Article
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1068, doi. 10.1007/s10637-015-0271-1
- By:
- Publication type:
- Article
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 664, doi. 10.1007/s10637-015-0231-9
- By:
- Publication type:
- Article
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 740, doi. 10.1007/s10637-014-0154-x
- By:
- Publication type:
- Article
Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 473, doi. 10.1007/s10637-013-0056-3
- By:
- Publication type:
- Article
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 4, p. 910, doi. 10.1007/s10637-012-9895-6
- By:
- Publication type:
- Article
Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 6, p. 866, doi. 10.1007/s10637-009-9306-9
- By:
- Publication type:
- Article
Psychological states and coping strategies after bereavement among spouses of cancer patients: a quantitative study in Japan.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 12, p. 3189, doi. 10.1007/s00520-012-1456-1
- By:
- Publication type:
- Article
Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 585, doi. 10.3390/cells8060585
- By:
- Publication type:
- Article
Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: Implications for carcinogenesis in upper aerodigestive tract.
- Published in:
- International Journal of Cancer, 2000, v. 88, n. 3, p. 342, doi. 10.1002/1097-0215(20001101)88:3<342::AID-IJC4>3.0.CO;2-I
- By:
- Publication type:
- Article
Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.
- Published in:
- 2012
- By:
- Publication type:
- journal article
UGT1A1 Haplotypes Associated with Reduced Glucuronidation and Increased Serum Bilirubin in Irinotecan-administered Japanese Patients with Cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 6, p. 501, doi. 10.1016/j.clpt.2004.01.010
- By:
- Publication type:
- Article
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences.
- Published in:
- Journal of Human Genetics, 2007, v. 52, n. 10, p. 804, doi. 10.1007/s10038-007-0186-6
- By:
- Publication type:
- Article
Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 5, p. 1008, doi. 10.1093/carcin/bgi035
- By:
- Publication type:
- Article
Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 10, p. 1759, doi. 10.1093/carcin/23.10.1759
- By:
- Publication type:
- Article
Expression of Integrin α3 in Gastric and Colorectal Cancers: Its Relation to Wall Contraction and Mode of Invasion.
- Published in:
- Cancer Science, 1995, v. 86, n. 10, p. 934, doi. 10.1111/j.1349-7006.1995.tb03004.x
- By:
- Publication type:
- Article
Inhibition of Colony Formation of Drug-resistant Human Tumor Cell Lines by Combinations of Interleukin-2-activated Killer Cells and Antitumor Drugs.
- Published in:
- Cancer Science, 1989, v. 80, n. 3, p. 265, doi. 10.1111/j.1349-7006.1989.tb02303.x
- By:
- Publication type:
- Article
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
- Published in:
- Journal of Surgical Oncology, 2016, v. 113, n. 4, p. 390, doi. 10.1002/jso.24151
- By:
- Publication type:
- Article
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 1, p. 123, doi. 10.1007/s10120-022-01335-4
- By:
- Publication type:
- Article
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 197, doi. 10.1007/s10120-021-01227-z
- By:
- Publication type:
- Article
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 803, doi. 10.1007/s10120-018-00923-7
- By:
- Publication type:
- Article
Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 793, doi. 10.1007/s10120-018-00922-8
- By:
- Publication type:
- Article
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 1, p. 69, doi. 10.1007/s10120-018-0843-9
- By:
- Publication type:
- Article
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 429, doi. 10.1007/s10120-017-0773-y
- By:
- Publication type:
- Article
Exposure--response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in secondline treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 2, p. 276, doi. 10.1007/s10120-017-0737-2
- By:
- Publication type:
- Article
Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407).
- Published in:
- Gastric Cancer, 2017, v. 20, n. 6, p. 1004, doi. 10.1007/s10120-017-0720-y
- By:
- Publication type:
- Article
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 3, p. 481, doi. 10.1007/s10120-016-0629-x
- By:
- Publication type:
- Article
Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 3, p. 407, doi. 10.1007/s10120-016-0631-3
- By:
- Publication type:
- Article
Dose-escalation study for the targeting of CD44v cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205).
- Published in:
- Gastric Cancer, 2017, v. 20, n. 2, p. 341, doi. 10.1007/s10120-016-0610-8
- By:
- Publication type:
- Article
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 902, doi. 10.1007/s10120-015-0542-8
- By:
- Publication type:
- Article
Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 1, p. 183, doi. 10.1007/s10120-015-0471-6
- By:
- Publication type:
- Article
A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
- Published in:
- Gastric Cancer, 2015, v. 18, n. 3, p. 458, doi. 10.1007/s10120-014-0394-7
- By:
- Publication type:
- Article
Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
- Published in:
- Gastric Cancer, 2015, v. 18, n. 2, p. 227, doi. 10.1007/s10120-014-0360-4
- By:
- Publication type:
- Article
Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 3, p. 522, doi. 10.1007/s10120-013-0309-z
- By:
- Publication type:
- Article
Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 2, p. 362, doi. 10.1007/s10120-013-0274-6
- By:
- Publication type:
- Article
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 1, p. 161, doi. 10.1007/s10120-013-0247-9
- By:
- Publication type:
- Article
Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 3, p. 324, doi. 10.1007/s10120-012-0187-9
- By:
- Publication type:
- Article
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 2, p. 175, doi. 10.1007/s10120-012-0167-0
- By:
- Publication type:
- Article
Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Future perspectives of chemotherapy for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2013, p. 60, doi. 10.1007/s10120-008-0461-z
- By:
- Publication type:
- Article
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.
- Published in:
- Gastric Cancer, 2012, v. 15, n. 3, p. 313, doi. 10.1007/s10120-011-0118-1
- By:
- Publication type:
- Article
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial).
- Published in:
- Gastric Cancer, 2011, v. 14, n. 3, p. 226, doi. 10.1007/s10120-011-0030-8
- By:
- Publication type:
- Article
Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article